Effects of tibolone on the breast

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 80, Issue 2, 1998, Pages 235-238

  Colacurci, Nicola ^a,b   Mele, Daniela ^a   De Franciscis, Pasquale ^a   Costa, Valentina ^a   Fortunato, Nicola ^a   De Seta, Lina ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b NONE   (Italy)

Author keywords

Breast; Hormone replacement therapy

Indexed keywords

ESTRADIOL; NOMEGESTROL ACETATE; TIBOLONE;

ADULT; ARTICLE; BREAST DISEASE; BREAST EPITHELIUM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAMMOGRAPHY; MASTALGIA; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0032188959     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(98)00129-8     Document Type: Article

References (9)

1. [1] Wolfe JN, Saftlas AF, Salane M. Mammographic parenchymal patterns and quantitative evaluation of mammographic densities: a case control-study. Am J Radiol 1987;148:1087-92.
2. [2] Stomper PC, Van Voorhis BJ, Ravnikar VA, Meyer JE. Mammographic changes associated with postmenopausal Hormone Replacement Therapy: a longitudinal study. Radiology 1990;174:487-90.
3. [3] Berkowitz JE, Gatewood OMB, Goldbloom LE, Gayler BW. Hormonal replacement therapy: mammographic manifestation. Radiology 1990;174:199-201.
4. [4] McNicholas MMJ, Heneghan JP, Milner MH, Tunney T, Hourihane JB, MacErlaine DP. Pain and increased mammographic density in women receiving hormone replacement therapy: a prospective study. Am J Radiol 1994;163:311-5.
5. [5] Laya MB, Gallagher JC, Schreiman JS, Larson EB, Watson P, Weinstein L. Effect of postmenopausal hormone replacement therapy on mammographic density and parenchymal pattern. Radiology 1995;196:433-7.
6. [6] Bird RE, Wallace TW, Yankaskas BC. Analysis of cancers missed at screening mammography. Radiology 1992;184:613-7.
7. [7] Laya MB, Larson EB, Taplin SH, White E. Effects of estrogen replacement therapy on the specificity and sensitivity of screening mammography. J Natl Cancer Inst 1996;88:643-9.
8. [8] O'Brien M, Montes A, Powles TJ. Hormone replacement therapy as treatment of breast cancer - a phase II of Org OD 14 (tibolone). Br J Cancer 1996;73:1086-8.
9. [9] Chetrite G, Kloosterbloer HJ, Pasqualini JR. Effect of tibolone (Org OD 14) and its metabolities on estrone sulphatase activity in MCF-7 and T-47D mammary cancer cells. Anticancer Res 1997;17:135-40.